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1. INTRODUCTION {#brb31575-sec-0005}
===============

Babinski sign, also known as the great toe sign, is the most sensitive and important indicator of an upper motor neuron lesion and was first described by Joseph Babinski in 1896. The sign consists of extension of the large toe and extension and fanning of the other toes during and immediately after the lateral plantar surface of the foot is stroked (Babinski, [1896](#brb31575-bib-0004){ref-type="ref"}). Several dozen surrogate responses have been described including Chaddock sign and Oppenheim sign based on alternative sites and types of stimulation, but all have the same physiological significance as the Babinski sign (Ghosh & Pradhan, [1998](#brb31575-bib-0009){ref-type="ref"}).

Ischemic stroke is a sudden interruption of blood supply to a structure due to occlusion or obstruction by a thrombus or embolus. The pyramidal tract is a large structure supplied by blood from many different arteries, with any occlusion leading to a wide variety of symptoms that include the presence of Babinski sign. However, this reflex has seldom been investigated in the acute ischemic stroke population by magnetic resonance imaging (MRI). A computed tomography study investigating the prevalence and reliability of upper motor neuron signs in the context of acute stroke reported a prevalence of Babinski sign of 64% (Louis, King, Sacco, & Mohr, [1995](#brb31575-bib-0015){ref-type="ref"}). Brain MRI can reveal structural details of acute ischemic stroke lesions and has greater sensitivity in detecting preexisting brain abnormalities.

It is not known whether the presence of Babinski sign is related to the functional outcome in stroke patients; however, if this is the case, it could provide prognostic information to neurologists and inform clinical decisions on how best to manage patients' care in order to accelerate recovery. To address this issue, the present study investigated the incidence and neuroimaging risk factors of Babinski sign and the relevance to functional outcome in Chinese acute ischemic stroke patients.

2. MATERIALS AND METHODS {#brb31575-sec-0006}
========================

2.1. Study subjects and setting {#brb31575-sec-0007}
-------------------------------

This study was a retrospective analysis of prospectively collected data (Cortical Cholinergic Pathways and Post‐stroke Delirium Study) that was conducted at Division I, Department of Neurology, Dongguan People\'s Hospital between June 1, 2017, and June 1, 2018. The inclusion criteria for the study subjects were as follows: (a) age over 18 years; (b) first acute ischemic stroke occurring within 7 days before admission; and (c) underwent complete brain MRI examination. The exclusion criteria were as follows: (a) history of stroke; (b) transient ischemic attack, cerebral hemorrhage, subdural hematoma, or subarachnoid hemorrhage; (c) medical history that could affect Babinski sign (e.g., motor neurone disease, Parkinson\'s disease, cervical or thoracic spondylotic myelopathy, multiple sclerosis, or neuromyelitis optica spectrum disorders); (d) lack of complete clinical and brain MRI data (e.g., incomplete MRI sequences or poor‐quality images); (e) death during hospitalization; (f) refusal to provide written, informed consent by patients or their relatives; and (g) severe comorbidities such as organ dysfunction or malignancy. A total of 351 patients were eligible to participate in the study (Figure [1](#brb31575-fig-0001){ref-type="fig"}). The study protocol was approved by the Ethics Committee of Dongguan People\'s Hospital, and written informed consent was obtained from all participants. The study was registered at the Chinese Clinical Trial Registry (ChiCTR1800014982, URL: <http://www.chictr.org.cn/index.aspx>).

![Patient selection process](BRB3-10-e01575-g001){#brb31575-fig-0001}

2.2. Collection of demographic and clinical data {#brb31575-sec-0008}
------------------------------------------------

Demographic and clinical information including age, sex, and vascular risk factors was prospectively recorded on a standard data collection form. The severity of stroke was assessed with the National Institutes of Health Stroke Scale (NIHSS) (Brott et al., [1989](#brb31575-bib-0005){ref-type="ref"}). The subtype of ischemic stroke was determined by neurologists during patient hospitalization based on the Trial of ORG 10172 in the Acute Stroke Treatment classification system (Adams et al., [1993](#brb31575-bib-0001){ref-type="ref"}).

2.3. Assessment of Babinski sign {#brb31575-sec-0009}
--------------------------------

Each patient was examined by one senior neurologist (JFQ, YLL, GPL, DHQ, or ZQW) according to a standard protocol following admission to the Stroke Unit. In addition to the Babinski sign, other upper motor neuron signs including Chaddock sign, Oppenheim sign, deep tendon hyperreflexia, and ankle clonus were recorded. The Babinski sign is not always observed within a few hours of acute ischemic stroke, but could be positive after admission (Louis et al., [1995](#brb31575-bib-0015){ref-type="ref"}). We tested for the Babinski sign and other upper motor neuron signs three times to confirm our results. The first examination was conducted at admission, with follow‐up examinations between days 1 and 3 and between days 5 and 7 after admission. These categorical variables were recorded as present or absent; the signs were considered as present if one of the three examinations yielded a positive result. If a patient\'s Babinski sign was negative at admission but was positive thereafter, it was defined as an altered Babinski sign; a positive sign from the time of admission was classified as persistent.

2.4. Follow‐up of participants {#brb31575-sec-0010}
------------------------------

All participants were followed up for 3 months via telephone. Clinical outcome was determined according to the modified Rankin Scale (mRS), and functional status was evaluated with the Lawton Activities of Daily Living (ADL) scale (Lawton & Brody, [1969](#brb31575-bib-0014){ref-type="ref"}) comprising the basic and instrumental ADL. The former measures the capacity for toilet activity, feeding, dressing, grooming, ambulation, and bathing; the latter examines the patient\'s ability to use a telephone, shop, prepare food, perform housekeeping and laundry, use a mode of transportation, take responsibility for his/her own medications, and handle finances. The total ADL score was calculated as the sum of points for each item and ranged from 14 to 56, with a higher score reflecting worse performance. Poor functional outcome was defined as an ADL score higher than the 75% quartile, and a low mRS score was defined as ≥3 points. Recurrence of stroke and death during the follow‐up period was also recorded.

2.5. MRI assessment {#brb31575-sec-0011}
-------------------

Brain MRI scans including T1‐ and T2‐weighted imaging and diffusion‐weighted imaging (DWI) were performed on each subject with a Sonata 3.0‐T system (Siemens Medical) within 7 days of hospital admission. A DWI spin‐echo (SE) echo‐planar sequence (EPI; repetition time \[TR\]/echo time \[TE\]/excitation = 2,162/76/1, matrix = 128 × 128, field of view \[FOV\] = 230 mm, slice thickness/gap = 6/1 mm, EPI factor = 47, acquisition time = 25.9 s) with three orthogonally applied gradients and *b* values of 0 and 1,000 was used. Axial SE T1 (TR/TE/excitation = 488/15/1, FOV = 230 mm, slice thickness/gap = 6/1 mm, matrix = 256 × 256, and time of acquisition = 1 min 24.8 s) and turbo spin‐echo T2 (TR/TE/excitation = 3,992/110/2, turbo factor = 15, FOV = 230 mm, slice thickness/gap = 6/1 mm, matrix = 512 × 512, and acquisition time = 1 min 55.8 s) images were also acquired.

A neurologist (YKC) who was blinded to patients' clinical information and assessment results evaluated the following MRI parameters.

### 2.5.1. Brain infarct {#brb31575-sec-0012}

The site and volume of acute lesions were determined from the DWI sequence. The sites of acute infarct were divided into cortical (frontal, temporal, parietal, occipital, and limbic lobes), subcortical (corona radiata and basal ganglia), and infratentorial (medulla oblongata, pons, mesencephalon, and cerebellum) regions. The total acute infarct area in DWI was measured from manually traced outlines. Acute infarct was defined as an area of restricted water diffusion with a *b* value of 1,000 combined with hypointensity on the corresponding apparent diffusion coefficient map. The total volume was calculated by multiplying the total area by the sum of the slice thickness and gap.

### 2.5.2. White matter lesions (WMLs) {#brb31575-sec-0013}

The severity of WMLs was graded on a 4‐point scale (Fazekas, Chawluk, Alavi, Hurtig, & Zimmerman, [1987](#brb31575-bib-0007){ref-type="ref"}). Periventricular and deep white matter hyperintensities were separately scored on fluid attenuation inversion recovery images.

Intrarater reliability tests were carried out by the same MRI rater (YKC) on 10 stroke patients. The intrarater agreement of MRI measurements was good to excellent (infarct volume intraclass coefficient, 0.83; site of infarction intrarater kappa, 0.85; and WML intrarater kappa, 0.82).

2.6. Statistical analysis {#brb31575-sec-0014}
-------------------------

Statistical analyses were performed using SPSS v.24.0 for Windows (SPSS Inc.). Descriptive data are presented as a proportion, mean, or median as appropriate. Potential risk factors were compared between patients with and those without Babinski sign by univariate analysis. A backward elimination procedure was used in the logistic regression analysis; presence of Babinski sign was the dependent variable. Risk factors with a *p* value \<.05 were analyzed by multivariate logistic regression analysis using a backward stepwise selection strategy. Correlation analysis was performed to test the collinearity between candidate independent variables. If the correlation coefficient between any two risk factors was ≥0.40, variables with a lower *p* value were entered into the logistic regression. We also analyzed the relationship between Babinski sign and low ADL and mRS scores after adjusting for potential confounds. The odds ratio (OR) of any independent risk factor was interpreted as the risk of poor outcome when all other risk factors were kept constant. The significance level was set at .05 (two‐sided).

3. RESULTS {#brb31575-sec-0015}
==========

Of the 351 eligible patients, 249 (70.9%) were male and 102 (29.1%) were female, with a mean age of 61.1 years (range, 19--91 years). The median NIHSS score at the time of admission was 4 (range, 0--28). The baseline characteristics of the study population are summarized in Table [1](#brb31575-tbl-0001){ref-type="table"}. The distribution of acute infarct according to Babinski sign is shown in Figure [2](#brb31575-fig-0002){ref-type="fig"}.

###### 

Demographic and clinical characteristics of the study population

+-----------------------------------------------------------------+----------------------------------+
| Characteristic                                                  | Mean (*SD*)/median (IQR)/*n* (%) |
|                                                                 |                                  |
|                                                                 | (*n* = 351)                      |
+=================================================================+==================================+
| Age (years)[a](#brb31575-note-0003){ref-type="fn"}              | 61.1 (14.6)                      |
+-----------------------------------------------------------------+----------------------------------+
| Males[b](#brb31575-note-0004){ref-type="fn"}                    | 249 (70.9%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Hypertension[b](#brb31575-note-0004){ref-type="fn"}             | 238 (67.8%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Diabetes mellitus[b](#brb31575-note-0004){ref-type="fn"}        | 87 (24.8%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Atrial fibrillation[b](#brb31575-note-0004){ref-type="fn"}      | 40 (11.4%)                       |
+-----------------------------------------------------------------+----------------------------------+
| NIHSS on admission[c](#brb31575-note-0005){ref-type="fn"}       | 4 (2--7)                         |
+-----------------------------------------------------------------+----------------------------------+
| Intravenous thrombolysis[b](#brb31575-note-0004){ref-type="fn"} | 20 (5.7%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Stroke subtype[b](#brb31575-note-0004){ref-type="fn"}           |                                  |
+-----------------------------------------------------------------+----------------------------------+
| Large artery                                                    | 149 (42.5%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Small artery                                                    | 101 (28.8%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Cardioembolism                                                  | 35 (10%)                         |
+-----------------------------------------------------------------+----------------------------------+
| Other etiologies                                                | 15 (4.3%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Unknown etiology                                                | 51 (14.5)                        |
+-----------------------------------------------------------------+----------------------------------+
| Location of infarct[b](#brb31575-note-0004){ref-type="fn"}      |                                  |
+-----------------------------------------------------------------+----------------------------------+
| Frontal lobe                                                    | 112 (31.9%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Parietal lobe                                                   | 88 (25.1%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Temporal lobe                                                   | 74 (21.1%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Occipital lobe                                                  | 49 (14%)                         |
+-----------------------------------------------------------------+----------------------------------+
| Limbic lobe                                                     | 66 (18.8%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Corona radiata                                                  | 156 (44.4%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Basal ganglia                                                   | 159 (45.3%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Medulla oblongata                                               | 8 (2.3%)                         |
+-----------------------------------------------------------------+----------------------------------+
| Pons                                                            | 57 (16.2%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Mesencephalon                                                   | 13 (3.7%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Cerebellum                                                      | 30 (8.5%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Cortical region                                                 | 151 (43%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Subcortical region                                              | 245 (69.8%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Infratentorial region                                           | 89 (25.4%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Infarct volume[c](#brb31575-note-0005){ref-type="fn"}           | 1.95 (0.755--9.275)              |
+-----------------------------------------------------------------+----------------------------------+
| PVH[c](#brb31575-note-0005){ref-type="fn"}                      | 1 (0--2)                         |
+-----------------------------------------------------------------+----------------------------------+
| DWMH[c](#brb31575-note-0005){ref-type="fn"}                     | 1 (0--1)                         |
+-----------------------------------------------------------------+----------------------------------+
| Babinski sign (+)[b](#brb31575-note-0004){ref-type="fn"}        | 115 (32.8%)                      |
+-----------------------------------------------------------------+----------------------------------+
| Chaddock sign (+)^b^                                            | 53 (15.1%)                       |
+-----------------------------------------------------------------+----------------------------------+
| Oppenheim sign (+)^b^                                           | 56 (16%)                         |
+-----------------------------------------------------------------+----------------------------------+
| Hyperreflexic sign (+)^b^                                       | 31 (8.8%)                        |
+-----------------------------------------------------------------+----------------------------------+
| Clonus sign (+)[b](#brb31575-note-0004){ref-type="fn"}          | 25 (7.1%)                        |
+-----------------------------------------------------------------+----------------------------------+

Abbreviations: DWMH, deep white matter hyperintensities; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; PVH, periventricular hyperintensities.

Mean (*SD*).

n (%).

Median (IQR).
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![Distribution of patients with Babinski sign](BRB3-10-e01575-g002){#brb31575-fig-0002}

3.1. Incidence of Babinski sign {#brb31575-sec-0016}
-------------------------------

Babinski sign was observed in 115 of 351 (32.8%) patients in the acute phase of ischemic stroke. Of the 115 patients, 17 (14.8%) were negative for the Babinski sign at admission but switched to a positive status thereafter. The other manifestations included Chaddock sign (*n* = 53), Oppenheim sign (*n* = 56), deep tendon hyperreflexia (*n* = 31), and ankle clonus (*n* = 25).

3.2. Univariate analysis {#brb31575-sec-0017}
------------------------

In the univariate analysis, patients presenting with Babinski sign had higher NIHSS scores at admission and more frequent atrial fibrillation and cardioembolism than their counterparts without Babinski sign. They also had higher rates of infarct in the frontal, temporal, and limbic lobes and basal ganglia as well as larger infarct volume (Table [2](#brb31575-tbl-0002){ref-type="table"}).

###### 

Risk factors for Babinski sign in the univariate analysis

  Variable                                                          Subjects with Babinski sign (*n* = 115)   Subjects without Babinski sign (*n* = 236)   *t*/*χ* ^2^/*z* value   *p* value
  ----------------------------------------------------------------- ----------------------------------------- -------------------------------------------- ----------------------- -----------
  Age (years)[a](#brb31575-note-0007){ref-type="fn"}                61.7 (15.4)                               60.8 (14.2)                                  1.788                   .182
  Males[b](#brb31575-note-0008){ref-type="fn"}                      80 (69.6%)                                169 (71.6%)                                  0.157                   .692
  Hypertension[b](#brb31575-note-0008){ref-type="fn"}               70 (60.9%)                                168 (71.2%)                                  3.77                    .052
  Diabetes mellitus[b](#brb31575-note-0008){ref-type="fn"}          29 (25.2%)                                58 (24.6%)                                   0.017                   .896
  Atrial fibrillation[b](#brb31575-note-0008){ref-type="fn"}        22 (19.1%)                                18 (7.6%)                                    10.133                  .001
  NIHSS on admission[c](#brb31575-note-0009){ref-type="fn"}         7 (3--12)                                 3 (1--5)                                     −7.074                  \< .001
  Intravenous thrombolysis[b](#brb31575-note-0008){ref-type="fn"}   8 (7%)                                    12 (5.1%)                                    0.504                   .478
  Stroke subtype[b](#brb31575-note-0008){ref-type="fn"}                                                                                                    11.2                    .024
  Large artery                                                      47 (40.9%)                                102 (43.2%)                                                           
  Small artery                                                      30 (26.1%)                                71 (30.1%)                                                            
  Cardioembolism                                                    20 (17.4%)                                15 (6.4%)                                                             
  Other etiologies                                                  5 (4.3%)                                  10 (4.2%)                                                             
  Unknown etiology                                                  13 (11.3%)                                38 (16.1%)                                                            
  Location of infarct[b](#brb31575-note-0008){ref-type="fn"}                                                                                                                       
  Frontal lobe                                                      48 (41.7%)                                64 (27.1%)                                   7.607                   .006
  Parietal lobe                                                     35 (30.4%)                                53 (22.5%)                                   2.619                   .106
  Temporal lobe                                                     35 (30.4%)                                39 (16.5%)                                   8.991                   .003
  Occipital lobe                                                    18 (15.7%)                                31 (13.1%)                                   0.408                   .523
  Limbic lobe                                                       33 (28.7%)                                33 (14%)                                     10.962                  .001
  Corona radiata                                                    50 (32.1%)                                106 (44.9%)                                  0.065                   .799
  Basal ganglia                                                     70 (60.9%)                                89 (37.7%)                                   16.734                  \< .001
  Medulla oblongata                                                 1 (0.9%)                                  7 (3%)                                       1.526                   .217
  Pons                                                              21 (18.3%)                                36 (15.3%)                                   0.514                   .473
  Mesencephalon                                                     7 (6.1%)                                  6 (2.5%)                                     2.724                   .099
  Cerebellum                                                        8 (7%)                                    22 (9.3%)                                    0.554                   .457
  Cortical region                                                   58 (50.4%)                                93 (39.4%)                                   3.836                   .5
  Subcortical region                                                87 (75.5%)                                158 (66.9%)                                  2.778                   .096
  Infratentorial region                                             28 (24.3%)                                61 (25.8%)                                   0.092                   .762
  Infarct volume[c](#brb31575-note-0009){ref-type="fn"}             4.365 (1--20.79)                          1.395 (0.647--6.207)                         −4.233                  \< .001
  PVH[c](#brb31575-note-0009){ref-type="fn"}                        1 (0--2)                                  1 (0--2)                                     −0.565                  .572
  DWMH[c](#brb31575-note-0009){ref-type="fn"}                       1 (0--1)                                  1 (0--1)                                     −0.541                  .589

Abbreviations: DWMH, deep white matter hyperintensities; NIHSS, National Institutes of Health Stroke Scale; PVH, periventricular hyperintensities.

Mean (*SD*), *t* test.

*n*(%), chi‐square test.

*M* (upper quartile--lower quartile), Mann‐Whitney *U* test.
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3.3. Multivariate logistic regression analysis {#brb31575-sec-0018}
----------------------------------------------

Infarct volume was not included in the multivariate logistic regression model as it was highly correlated with NIHSS score (r = .543). Atrial fibrillation, NIHSS score at admission, stroke subtype, and infarct in the frontal, temporal, and limbic lobes and basal ganglia were entered into the model. A higher NIHSS score and basal ganglia infarct were significant predictors of Babinski sign. The presence of a basal ganglia infarct had an OR of 1.738 (95%CI = 1.055--2.863, *p* = .03) (Table [3](#brb31575-tbl-0003){ref-type="table"}). Additionally, there was no difference in the rates of poor functional outcome between patients with persistent versus altered Babinski sign (poor ADL, 37% vs. 23.5%, *p* = .134; poor mRS, 60.5% vs. 47.1%, *p* = .306, respectively). After adjusting for confounds, the presence of Babinski sign (including altered Babinski sign) was not a predictor of poor outcome, as measured by the ADL scale and mRS (Table [4](#brb31575-tbl-0004){ref-type="table"}).

###### 

Multivariate logistic regression analysis of risk factors for subjects with Babinski sign

  Variable              *β*      OR (95% CI)            *p* value
  --------------------- -------- ---------------------- -----------
  Atrial fibrillation   0.402    1.495 (0.681--3.283)   .316
  NIHSS on admission    0.149    1.161 (1.102--1.222)   \<.001
  Stroke subtype        0.012    1.012 (0.852--1.203)   .889
  Frontal lobe          0.367    1.443 (0.853--2.44)    .172
  Temporal lobe         −0.365   0.694 (0.337--1.43)    .322
  Limbic lobe           0.175    1.191 (0.561--2.53)    .648
  Basal ganglia         0.553    1.738 (1.055--2.863)   .03

Abbreviation: NIHSS, National Institutes of Health Stroke Scale.
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###### 

Outcome of subjects with Babinski sign[a](#brb31575-note-0011){ref-type="fn"}

  Variable                mRS     ADL                                                          
  ----------------------- ------- ---------------------- ------ ------- ---------------------- ------
  Babinski sign (+)       −0.11   0.989 (0.509--1.922)   .957   0.194   1.214 (0.598--2.465)   .592
  Altered Babinski sign   0.106   1.112 (0.278--4.44)    .881   0.431   1.539 (0.422--5.617)   .514

Adjusted for age, NIHSS score on admission, stroke subtype, and atrial fibrillation.

John Wiley & Sons, Ltd

4. DISCUSSION {#brb31575-sec-0019}
=============

In this present study, we found that the incidence of Babinski sign was 32.8% in the acute stage of overall ischemic stroke. The presence of Babinski sign was associated with higher NIHSS score and infarct in the basal ganglia. However, patients with Babinski sign did not have a worse functional outcome than those without this reflex, suggesting that the presence or absence of Babinski sign cannot be used to predict the prognosis of acute ischemic stroke patients.

Babinski sign was more frequently observed in our patients than other upper neuron signs of acute ischemic stroke, with an incidence of 32.8%. A retrospective review of 1,600 cases of pyramidal tract syndrome revealed that only 30% of cases were considered acute (Lassek, [1945](#brb31575-bib-0013){ref-type="ref"}). An investigation of acute hemorrhagic and ischemic stroke patients found an incidence of Babinski sign of 64.8%. The divergent findings of these studies may be attributable to the heterogeneous cohorts and variable periods of examination (Louis et al., [1995](#brb31575-bib-0015){ref-type="ref"}). In our study, patients were evaluated within 1 week after hospital admission for acute ischemic stroke, yielding a more homogeneous study population and defined examination period. Thus, Babinski sign has little clinical relevance for the management of acute ischemic stroke.

Our results showed that higher NIHSS score at admission predicted the presence of Babinski sign. The NIHSS is widely used to assess stroke severity (Lyden, [2017](#brb31575-bib-0016){ref-type="ref"}) and mainly reflects the motor ability of proximal limbs; it does not include a detailed assessment of the cranial nerves, and relatively low scores may be observed in patients with disabling infarctions of the brainstem or cerebellum (Kasner, [2006](#brb31575-bib-0011){ref-type="ref"}). A higher NIHSS score is correlated with more severe motor lesions, indicating a higher probability of a positive Babinski sign.

Few studies have investigated the relationship between lesion pattern and Babinski sign by brain MRI. It was previously suggested that cortical but not subcortical lesions predict the Babinski sign (Deng, Jia, Zhang, Guo, & Yang, [2013](#brb31575-bib-0006){ref-type="ref"}), the presence of which always implies upper motor neuron dysfunction in the brain or spinal cord in adults (Ambesh, Paliwal, Shetty, & Kamholz, [2017](#brb31575-bib-0002){ref-type="ref"}). The pyramidal tract is concentrated in the basal ganglia after emerging from the cortex (Ashby, Andrews, Knowles, & Lance, [1972](#brb31575-bib-0003){ref-type="ref"}), and infarcts involving this structure can increase the risk of Babinski sign. Indeed, our study showed that basal ganglia infarcts were a predictor of this reflex.

The Babinski sign is a very important part of neurological examinations as it is the most important indicator of an upper motor neuron lesion (Babinski, [1896](#brb31575-bib-0004){ref-type="ref"}). Our results indicate that the presence of Babinski sign does not predict poor functional outcome of acute stroke patients at the 3‐month follow‐up. The mRS reflects the overall degree of disability of patients including physical function and prognosis (van Swieten, Koudstaal, Visser, Schouten, & Gijn, [1988](#brb31575-bib-0018){ref-type="ref"}), whereas the ADL scale primarily evaluates memory and executive functions (Fukui & Lee, [2009](#brb31575-bib-0008){ref-type="ref"}). The Babinski sign is a common manifestation in acute ischemic stroke patients that is generally attributed to a pyramidal tract lesion and is unrelated to stroke severity (Lance, [2002](#brb31575-bib-0012){ref-type="ref"}). However, the aim of our study was to determine whether it could predict functional outcome in stroke, rather than to question its importance.

Our study had the following advantages: (a) We examined consecutively recruited acute ischemic stroke patients; (b) we evaluated comprehensive neuroimaging parameters and obtained detailed data on location of infarcts and presence of WMLs; and (c) we analyzed the relationship between Babinski sign and clinical outcome. However, there were also some limitations to the study. Firstly, the sample size was relatively small; secondly, we did not evaluate other upper neuron signs such as spasticity and the Gordon sign. Finally, we did not assess upper neuron signs in the follow‐up and were therefore unable to adequately evaluate stroke severity.

In conclusion, a higher NIHSS score and basal ganglia infarct predict the presence of Babinski sign. However, Babinski sign is unrelated to functional outcome of acute stroke patients at the 3‐month follow‐up. Thus, neurologists should pay more attention to the functional status in stroke patients based on manifestations other than Babinski sign.
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